Assessment of the comparability of CLSI, EUCAST and Stokes antimicrobial susceptibility profiles for Escherichia coli uropathogenic isolates

References

• Stamm WE. Scientific and clinical challenges in the management of urinary tract infections. Am J Med. 2002;113(Suppl 1A):1S–4S.10.1016/S0002-9343(02)01053-7
   PubMedGoogle Scholar
• Little P, Merriman R, Turner S, et al. Presentation, pattern, and natural course of severe symptoms, and role of antibiotics and antibiotic resistance among patients presenting with suspected uncomplicated urinary tract infection in primary care: observational study. BMJ. 2010;340:b5633.10.1136/bmj.b5633
   PubMed Web of Science ®Google Scholar
• Guay DR. Contemporary management of uncomplicated urinary tract infections. Drugs. 2008;68(9):1169–1205.10.2165/00003495-200868090-00002
   PubMed Web of Science ®Google Scholar
• Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;6:229–241.10.1177/2042098614554919
   Google Scholar
• Biemer JJ. Antimicrobial susceptibility testing by the Kirby-Bauer disc diffusion method. Ann Clin Lab Sci. 1973;3(2):135–140.
   PubMedGoogle Scholar
• Guidoni EBM, Berezin ENS, et al. Antibiotic resistance patterns of pediatric community-acquired urinary infections. Braz J Infect Dis. 2008;12(4):321–323.10.1590/S1413-86702008000400013
   PubMed Web of Science ®Google Scholar
• EUCAST. (2012). Direct antimicrobial susceptibility testing [Internet]. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/General_documents/Direct_testing_guidance_note_Feb2012.pdf
   Google Scholar
• Gould IM. Towards a common susceptibility testing method? J Antimicrob Chemother. 2000;45(6):757–762.10.1093/jac/45.6.757
   PubMedGoogle Scholar
• Dudley MN., Ambrose PG., Bhavnani SM., et al. Background and rationale for revised clinical and laboratory standards institute interpretive criteria (breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I Cephalosporins and Aztreonam. Clin Infect Dis. 2013;56(9):1301–1309.
   PubMed Web of Science ®Google Scholar
• Wolfensberger A., Sax H., Weber R., et al. Change of antibiotic susceptibility testing guidelines from CLSI to EUCAST: Influence on cumulative hospital antibiograms. PLoS ONE. 2013;8(11):e79130.10.1371/journal.pone.0079130
   PubMed Web of Science ®Google Scholar
• EUCAST. (2016b). Setting breakpoints for new antimicrobial agents. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/EUCAST_SOPs/EUCAST_SOP_1.2_Setting_breakpoints_new_agents_20161121.pdf
   Google Scholar
• Matuschek E., Brown DFJ., Kahlmeter G.. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin Microbiol Infect. 2014;20(4):O255–O266.10.1111/1469-0691.12373
   PubMed Web of Science ®Google Scholar
• Doern GV. Antimicrobial susceptibility testing. J Clin Microbiol. 2011;49(9):S4.10.1128/JCM.00803-11
   Google Scholar
• Gosden PE., Andrews JM., Bowker KE., et al. Comparison of the modified stokes’ method of susceptibility testing with results obtained using MIC methods and British Society of Antimicrobial Chemotherapy breakpoints. J Antimicrob Chemother. 1998;42(2):161–169.10.1093/jac/42.2.161
   PubMed Web of Science ®Google Scholar
• CLSI. (2012). M02-A11 - Performance standards for antimicrobial disk susceptibility tests; Approved Standard – Eleventh Edition. Available from: https://www.bing.com/search?q=performance+standards+for+antimicrobial+disk+susceptibility+tests%3B+approved+standard+%E2%80%93+eleventh+edition&form=EDGTCT&qs=PF&cvid=3a31ee62a0ce4db6b60242275a1163a5&cc=GB&setlang=en-US
   Google Scholar
• EUCAST. (2017). EUCAST disk diffusion method for antimicrobial susceptibility testing Version 6.0. Available from: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Disk_test_documents/Version_5/Slide_show_v_6.0_EUCAST_Disk_Test.pdf
   Google Scholar
• CLSI. (2017). M100 - Performance standards for antimicrobial susceptibility testing - 27th edition. Available from: http://em100.edaptivedocs.info/GetDoc.aspx?doc=CLSI%20M100%20S27:2017&scope=use
   Google Scholar
• Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Disease-a-Month. 2003;49(2):71–82.10.1067/mda.2003.8
   PubMed Web of Science ®Google Scholar
• Kucheria R., Dasgupta P., Sacks H., Khan M., Sheerin N.. Urinary tract infections: new insights into a common problem. Postgrad M J. 2005;81(952):83–86.10.1136/pgmj.2004.023036
   PubMed Web of Science ®Google Scholar
• CLSI. (2008). Development of in vitro susceptibility testing criteria and quality control parameters. 3d edition. M23-A3. Wayne (PA): Clinical and Laboratory Standards Institute.
   Google Scholar
• Vellinga A., Cormican M., Hanahoe B., et al. Antimicrobial management and appropriateness of treatment of urinary tract infection in general practice in Ireland. BMC Fam Pract. 2011;12(1):143.10.1186/1471-2296-12-108
   PubMedGoogle Scholar